There is pressing need for third-party, tech-enabled training to enforcement agencies: BDCDA: Nandita Vijayasimha, Bengaluru ...

PCI once again opens portal for institutes to submit additional information for approval: Gireesh Babu, New Delhi Thursday, ...

Sanofi to present new data from 14 abstracts across multiple sclerosis at ECTRIMS 2025 congress in Barcelona, Spain: Paris Thursday, September 11, 2025, 13:00 Hrs [IST] New data f ...

Karyopharm Therapeutics Inc., a commercial-stage pharmaceutical company pioneering novel cancer therapies, announced that it has completed enrollment in the phase 3 SENTRY trial, which is evaluating ...

US FDA grants fast track designation to Greenwich LifeSciences’ GLSI-100 in the HLA-A*02 patient population: Stafford, Texas Thursday, September 11, 2025, 16:00 Hrs [IST] Greenw ...

Galderma introduces Alastin in China, supporting the skin’s natural regenerative abilities in a rapidly expanding market: Zug, Switzerland Thursday, September 11, 2025, 14:00 Hr ...

Chinese NMPA approves Sanofi’s Tzield as first disease-modifying therapy for adult and paediatric patients with stage 2 type 1 diabetes: Paris Thursday, September 11, 2025, 09:0 ...

Apollo MD calls healthcare and medical tourism India’s next engines of services-led growth: Our Bureau, Bengaluru Thursday, September 11, 2025, 14:30 Hrs [IST] Suneeta Reddy, pr ...

Rainbow Children’s Medicare expands Andhra Pradesh footprint with 100-bed greenfield hospital in Rajahmundry: Our Bureau, Bengaluru Thursday, September 11, 2025, 14:15 Hrs [IST] ...

Our Bureau, Mumbai Thursday, September 11, 2025, 16:30 Hrs [IST] ...

Implantica ramps-up production with 10,000 RefluxStop units in preparation for US launch, pending FDA PMA approval: Vaduz, Liechtenstein Thursday, September 11, 2025, 12:00 Hrs [I ...

IIT Kanpur researchers develop novel sensor to study how medicines activate vital receptors: Our Bureau, Mumbai Thursday, September 11, 2025, 16:15 Hrs [IST] Researchers at the In ...